Results 81 to 90 of about 23,635 (276)

A Case of Palmoplantar Vesiculobullous Lesions

JEADV Clinical Practice, EarlyView.
Ali Abid, Kelvin Truong, Jing Jing Li, Artiene Tatian   +3 more
wiley   +1 more source

Bispecific Dual‐Immune Checkpoint Inhibitor Associated Cutaneous Toxicity: A Report of Lorigerlimab Adverse Skin Reaction in Two Cancer Patients

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Lorigerlimab is a dual bispecific antibody (BsAb) targeting cytotoxic T‐lymphocyte‐associated protein 4 and programmed cell death protein 1 that is used for treatment of advanced solid cancers such as metastatic castration‐resistant prostate carcinoma.
Niloofar Sina, Fiorinda Muhaj, Volha Lenskaya, Doina Ivan, Victor G. Prieto, Jonathan L. Curry   +5 more
wiley   +1 more source

238 Pemphigus and bullous pemphigoid in the United States: A population-based study evaluating patient clinical characteristics and treatment trends [PDF]

, 2021
Yasmin Gutierrez, Sarah P. Pourali, Indira Singh, April W. Armstrong   +3 more
openalex   +1 more source

Bullous Pemphigoid [PDF]

Journal of General Internal Medicine, 2012
Barry, Ladizinski, Kachiu Cecelia, Lee
openaire   +3 more sources

A Case of Oropharyngeal Bullous Pemphigoid Presenting with Haemoptysis

Case Reports in Otolaryngology, 2015
Objective. Bullous pemphigoid is well known for its cutaneous features; however in rare cases it may present with mucosal involvement. We report a case of bullous pemphigoid presenting with haemoptysis, initially presenting to the Ear, Nose and Throat ...
C. M. Lee, H. K. Leadbetter, J. M. Fishman   +2 more
doaj   +1 more source

Autoimmune diseases and their manifestations on oral cavity: diagnosis and clinical management [PDF]

, 2018
Oral signs are frequently the first manifestation of autoimmune diseases. For this reason, dentists play an important role in the detection of emerging autoimmune pathologies.
Bossù, Maurizio, Di Carlo, Gabriele, Giovarruscio, Francesca, Polimeni, Antonella, Saccucci, Matteo, Salucci, Alessandro   +5 more
core   +2 more sources

Bullous pemphigoid of Lever against the background of combined somatic pathology

Лечащий Врач, 2021
Clinical observation of a rare bullous autoimmune dermatosis — bullous pemphigoid — in a patient with concomitant polyorganic somatic pathology is given.
E. N. Efanova, Yu. E. Rusak, E. A. Vasileva, A. A. Elmanbetova   +3 more
doaj  

Skin Fragility and Hyperpigmentation in a Patient With HIV

JEADV Clinical Practice, EarlyView.
Catalina Retamal, Maximiliano Maass, María Fernanda Martin   +2 more
wiley   +1 more source

Adjuvant therapy of severe and/or refractory bullous pemphigoid with immunoadsorption – A prospective monocenter pilot study

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives Bullous pemphigoid (BP) is the most common autoimmune blistering disease in the Western world. While remission is achieved in the majority of BP patients by long‐term use of corticosteroids with or without immunomodulants/immunosuppressants, national and international guidelines recommend adjuvant immunoadsorption (IA)
Maike M. Holtsche, Nina van Beek, Christoph M. Hammers, Artem Vorobyev, Michael Kasperkiewicz, Nina Schumacher, Philip Muck, Enno Schmidt   +7 more
wiley   +1 more source

Targeting type 2 inflammation in bullous pemphigoid: current and emerging therapeutic approaches [PDF]

, 2023
Wu Han Toh, Hua-En Lee, Chun‐Bing Chen
openalex   +1 more source